Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea

被引：0
|
作者：
Kim, David [1 ]
Lee, Jae Seung [1 ]
Chun, Ho Soo [1 ]
Lee, Hye Won [1 ]
Kim, Beom Kyung [1 ]
Park, Jun Yong [1 ]
Kim, Do Young [1 ]
Han, Kwang-Hyub [1 ]
Lee, Yu Rim [2 ]
Tak, Won Young [2 ]
Kweon, Young Oh [2 ]
Ahn, Sang Hoon [1 ]
Kim, Seung Up [1 ]
机构：
[1] Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea
[2] Kyungpook Natl Univ, Dept Internal Med, Daegu, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT454
引用
收藏
页码：S880 / S880
页数：1
相关论文
共 50 条
  • [1] Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious
    Giri, Suprabhat
    Darak, Harish
    Kasturi, Sunil
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (10) : 4962 - 4964
  • [2] Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious
    Suprabhat Giri
    Harish Darak
    Sunil Kasturi
    Digestive Diseases and Sciences, 2022, 67 : 4962 - 4964
  • [3] A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib
    Yang, Yu
    Wen, Feng
    Li, Jianliang
    Zhang, Pengfei
    Yan, Wenhui
    Hao, Ping
    Xia, Feng
    Bi, Feng
    Li, Qiu
    LIVER INTERNATIONAL, 2015, 35 (09) : 2147 - 2154
  • [4] Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
    Hui, Vicki Wing-Ki
    Chan, Stephen Lam
    Wong, Vincent Wai-Sun
    Liang, Lilian Yan
    Yip, Terry Cheuk-Fung
    Lai, Jimmy Che-To
    Yuen, Becky Wing-Yan
    Luk, Hester Wing-Sum
    Tse, Yee-Kit
    Lee, Hye-Won
    Chan, Henry Lik-Yuen
    Wong, Grace Lai-Hung
    JHEP REPORTS, 2020, 2 (06)
  • [5] The Progress of Antiviral Therapy in Patients with HBV-Related Liver Failure
    Zhou, Qiaoling
    Tang, Hong
    HEPATO-GASTROENTEROLOGY, 2013, 60 (128) : 1877 - 1880
  • [6] Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy
    Battistella, Sara
    Lynch, Erica N.
    Gambato, Martina
    Zanetto, Alberto
    Pellone, Monica
    Shalaby, Sara
    Sciarrone, Salvatore
    Ferrarese, Alberto
    Germani, Giacomo
    Senzolo, Marco
    Burra, Patrizia
    Russo, Francesco P.
    MINERVA GASTROENTEROLOGY, 2021, 67 (01): : 38 - 49
  • [7] Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
    Wei, Yanyan
    Ye, Wei
    Zhao, Wei
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [8] HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?
    Su, Tung-Hung
    Tseng, Tai-Chung
    Kao, Jia-Horng
    HEPATOLOGY, 2018, 67 (04) : 1634 - 1635
  • [9] Risk assessment of HBV-related HCC development using liver stiffness measurement
    Kim, S. U.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S11 - S12
  • [10] Tenofovir vs Entecavir Among Patients With HBV-Related HCC After Resection
    Li, Pengpeng
    Wang, Yuanyuan
    Yu, Jian
    Yu, Judian
    Tao, Qifei
    Zhang, Jinwei
    Lau, Wan Yee
    Zhou, Weiping
    Huang, Gang
    JAMA NETWORK OPEN, 2023, 6 (10) : E2340353
12345